Oxadiazole benzenesulfonamides as selective beta 3 Agonist for the treatment of Diabetes and Obesity
Oxadiazole substituted benzenesulfonamides are selective beta 3 adrenergic receptor agonists with very little beta 1 and beta 2 adrenergic receptor activity and as such the compounds are capable of increasing lipolysis and energy expenditure in cells. The
-
(2008/06/13)
More Articles about upstream products of 200502-64-3